{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:11:31Z","timestamp":1772169091721,"version":"3.50.1"},"reference-count":19,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Serum albumin and cholesterol levels predict survival in primary myelofibrosis, independent of each other and contemporary risk models. The cachexia index, determined by serum albumin and cholesterol levels, might further refine current prognostic models in myelofibrosis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018018051","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T20:18:50Z","timestamp":1536956330000},"page":"1980-1984","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels"],"prefix":"10.1182","volume":"2","author":[{"given":"Ayalew","family":"Tefferi","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Nicolosi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Penna","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mythri","family":"Mudireddy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Szuber","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Division of Hematopathology, Department of Laboratory Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[{"name":"Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Animesh D.","family":"Pardanani","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"13","key":"2019111617090469500_B1","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019111617090469500_B2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111617090469500_B3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status","volume":"29","author":"Gangat","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"2019111617090469500_B4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1200\/JCO.2017.76.4886","article-title":"MIPSS70: Mutation-Enhanced International Prognostic Score System for transplantation-age patients with primary myelofibrosis","volume":"36","author":"Guglielmelli","year":"2018","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111617090469500_B5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"key":"2019111617090469500_B6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-981-10-6020-5_11","article-title":"Metabolic changes during cancer cachexia pathogenesis","volume":"1026","author":"Shyh-Chang","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"18","key":"2019111617090469500_B7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin Biochem"},{"issue":"1","key":"2019111617090469500_B8","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI114419","article-title":"Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia","volume":"85","author":"Brenner","year":"1990","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111617090469500_B9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/0026-0495(86)90232-5","article-title":"Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia","volume":"35","author":"Ginsberg","year":"1986","journal-title":"Metabolism"},{"issue":"3","key":"2019111617090469500_B10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.7326\/0003-4819-110-3-208","article-title":"Low-density lipoprotein (LDL) distribution shown by 99mtechnetium-LDL imaging in patients with myeloproliferative diseases","volume":"110","author":"Vallabhajosula","year":"1989","journal-title":"Ann Intern Med"},{"issue":"3","key":"2019111617090469500_B11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-96-3-311","article-title":"Increased low-density-lipoprotein catabolism in myeloproliferative disorders","volume":"96","author":"Ginsberg","year":"1982","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019111617090469500_B12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(81)90212-6","article-title":"Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity","volume":"71","author":"Gilbert","year":"1981","journal-title":"Am J Med"},{"issue":"11","key":"2019111617090469500_B13","doi-asserted-by":"crossref","first-page":"751a","DOI":"10.1182\/blood.V110.11.2548.2548","article-title":"Hypocholesterolemia is independently associated with decreased survival in patients with primary myelofibrosis: An analysis of lipid profiles in 558 myeloproliferative patients [abstract]","volume":"110","author":"Mesa","year":"2007","journal-title":"Blood"},{"issue":"22","key":"2019111617090469500_B14","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.3918.3918","article-title":"Weight loss, splenomegaly, and hypocholesterolemia in myeloproliferative neoplasms: Patterns and relevance from the pre JAK2 inhibitor era [abstract]","volume":"114","author":"Mesa","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111617090469500_B15","article-title":"Myelofibrosis-related hypocholesterolemia in hematologic malignancies [abstract]","volume":"88","author":"Rak","year":"1996","journal-title":"Blood"},{"issue":"21","key":"2019111617090469500_B16","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2851.2851","article-title":"Decreased levels of total or HDL cholesterol in primary myelofibrosis are associated with shortened survival: DIPSS-Plus independent prognostic value [abstract]","volume":"120","author":"Sulai","year":"2012","journal-title":"Blood"},{"issue":"3-4","key":"2019111617090469500_B17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00508-018-1318-z","article-title":"Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis","volume":"130","author":"Lucijanic","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"2019111617090469500_B18","article-title":"Serum albumin is a strong predictor of survival in myelofibrosis, independent of IPSS, DIPSS, and DIPSS plus scores [abstract]","volume":"102","author":"Kuykendall","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"2019111617090469500_B19","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/15\/1980\/881422\/advances018051.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/15\/1980\/881422\/advances018051.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T22:39:20Z","timestamp":1604961560000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/15\/1980\/15967\/Development-of-a-prognostically-relevant-cachexia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":19,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018018051","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]}}}